ClinicalTrials.gg
Status unknownNCT01793571Updated Feb 15, 2013

Pilot Study on the Effectiveness of a TAP-block for Inguinal Hernia Repair

An interventional study of TAP block in Hernia Inguinal, sponsored by Dijklander Ziekenhuis. Status unknown at 1 site in Netherlands. Open to male participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-02-15.

Sponsored by Dijklander Ziekenhuis · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Feb 2013), so the status shown — last known as Active, not recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
Male
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 10 studies in Hernia, Inguinal with a site in Netherlands — 2 open to participants now, 2 under way, none of them phase 3. Hernia, Inguinal · Netherlands.

Started
2012
the only one that year
No phase
4 of 10
1 open now
Registered
5th of 10
by date
Lead sponsor
1 of 10
Dijklander Ziekenhuis

Among the 10 studies in Hernia, Inguinal with a site in Netherlands, this one is the only one that started in 2012, is one of 4 with no phase, and was the 5th registered.

Hernia, Inguinal

545 studies on the registry are indexed under Hernia, Inguinal; 93 are open to participants now.

Browse Hernia, Inguinal studies →

Open to participants now

2 of the 10 studies in Hernia, Inguinal with a site in Netherlands are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in Netherlands have not opened yet or have stopped. Only those recruiting at a site in Netherlands →

Who these studies take

Of the 56 Hernia, Inguinal studies recruiting now, 30 (54%) set no upper age limit and 17 (30%) stop at 75 or younger; 16 take children under 18; 9 take healthy volunteers.

This study: 18 Years to 80 Years · male · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Hernia, Inguinal with a site in Netherlands, or all of them as a file.
02

Study summary

An prospective double blinded randomised trial,whether the use of an perioperative echoguided unilateral TAP block has an superior effect on postoperative pain after open hernia inguinal repair compared to wound infiltration with a long acting local anesthetic.

Read the detailed description

Hernia inguinal repair is the most common operation performed by general surgeons in the Netherlands. On of the most common complications after hernia repair is postoperative and chronic pain. Postoperative pain is an expected but undesirable effect after an operation, which can result in an prolonged hospital stay or longer time to return to full normal daily activities. There are indications that an insufficient treatment of postoperative pain is a risk factor for persistent or chronic pain after open inguinal hernia repair. Chronic pain is not uncommon after hernia repair, with an incidence of 11%.

The objective of this study is to determine, whether the use of an perioperative echo guided unilateral TAP block has an superior effect on postoperative pain after open hernia inguinal repair compared to wound infiltration with a long acting local anesthetic. There will be no further analysis in this study regarding the incidence of open hernia inguinal repair and chronic pain.

03

Conditions studied

  • Hernia Inguinal

Keywords

  • Abdominal Muscles/Ultrasonography
  • Adult
  • Ambulatory Surgical Procedures
  • Anesthetics, Local/Administration & Dosage
  • Levobupivacaine/Administration & Dosage
  • Levobupivacaine/Analogs & Derivatives
  • Hernia, Inguinal/Surgery
  • Humans
  • Nerve Block/Methods
  • Pain Measurement/Methods
  • Pain, Postoperative/Prevention & Control
  • Ultrasonography, Interventional
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age between 18 and 80 year, competent, elective surgical treatment, (BMI) between 20-35.

Exclusion criteria

Exclusion Criteria:

  • fever, a coagulation disorder, patients with kidney and liverfaillure, an infection at the place where the puncture place, preoperative use of narcotic and nonsteroidal antiinflammatory drugs.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    TAP block

    20 ml Levobupivacaine 0,5%

    Procedure: TAP block

  • Active comparator
    Local wound infiltration

    20 ml levobupivacaine 0,5%

    Procedure: TAP block

Interventions

  • ProcedureTAP block

    2 groups, group A a TAP block with 20 ml of Levobupivacaine 0,5% and subcutaneous wound infiltration with 20 ml sodium chloride (to blind patient and physician) and group B, TAP block with 20 ml sodium chloride and subcutaneous wound infiltration with 20 ml Levobupivacaine 0,5% (to blind patient and physician)

06

What researchers measure

Primary outcomes

  1. Primary objective is to analyse, differences in pain scores between the 2 groups until 48 hours after the operation

    Time frame: 48 hours

Secondary outcomes

  1. time to to first use of intravenous morfine

    Time frame: 48 hours

  2. the total amount of titrated postoperative morfine

    Time frame: 48 hours

  3. use of tramadol at home

    Time frame: 48 hours

  4. patient satisfaction

    Time frame: 48 hours

  5. the incidence of nausea and vomiting

    Time frame: 48 hours

07

Study locations

1 site
  • Westfriesgasthuis
    Hoorn, Noord-Holland 1620AR, Netherlands
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Sep 2012, a primary completion of Mar 2013 and a completion of Mar 2013. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 17, 2013
First posted
Feb 15, 2013
Start
Sep 2012
Primary completionEst.
Mar 2013
CompletionEst.
Mar 2013
Last update
Feb 15, 2013
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 15, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01793571
Lead sponsor
Dijklander Ziekenhuis
Responsible party
Peter Dijkhuizen (MPA Anesthesiology, Dijklander Ziekenhuis) — Principal investigator
First posted
Feb 15, 2013
Start date
Sep 2012
Primary completion
Mar 2013 (estimated)
Completion
Mar 2013 (estimated)
Last update
Feb 15, 2013

Study contacts

Jens P Hering, Anesthesiologist
principal investigator · Dijklander Ziekenhuis

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion